Literature DB >> 24764298

Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Marta M Fay1, James M Clegg1, Kimberly A Uchida2, Matthew A Powers1, Katharine S Ullman3.   

Abstract

The role of programmed cell death 4 (PDCD4) in tumor biology is context-dependent. PDCD4 is described as a tumor suppressor, but its coexpression with protein arginine methyltransferase 5 (PRMT5) promotes accelerated tumor growth. Here, we report that PDCD4 is methylated during nutrient deprivation. Methylation occurs because of increased stability of PDCD4 protein as well as increased activity of PRMT5 toward PDCD4. During nutrient deprivation, levels of methylated PDCD4 promote cell viability, which is dependent on an enhanced interaction with eIF4A. Upon recovery from nutrient deprivation, levels of methylated PDCD4 are regulated by phosphorylation, which controls both the localization and stability of methylated PDCD4. This study reveals that, in response to particular environmental cues, the role of PDCD4 is up-regulated and is advantageous for cell viability. These findings suggest that the methylated form of PDCD4 promotes tumor viability during nutrient deprivation, ultimately allowing the tumor to grow more aggressively.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Molecular Cell Biology; Nutrient Deprivation; Oncogene; PDCD4; PRMT5; Protein Methylation; Translation Initiation Factor; Tumor Cell Biology; Tumor Suppressor Gene; eIF4A

Mesh:

Substances:

Year:  2014        PMID: 24764298      PMCID: PMC4067190          DOI: 10.1074/jbc.M113.541300

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms.

Authors:  Mayumi Nakashima; Hiroshi Hamajima; Jinghe Xia; Shinji Iwane; Yasunori Kwaguchi; Yuichiro Eguchi; Toshihiko Mizuta; Kazuma Fujimoto; Iwata Ozaki; Sachiko Matsuhashi
Journal:  Biochim Biophys Acta       Date:  2010-05-12

2.  Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Authors:  Nicole LaRonde-LeBlanc; Arti N Santhanam; Alyson R Baker; Alexander Wlodawer; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

3.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Authors:  Alexey Palamarchuk; Alexey Efanov; Vadim Maximov; Rami I Aqeilan; Carlo M Croce; Yuri Pekarsky
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

5.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

Review 6.  Tumor microenvironmental physiology and its implications for radiation oncology.

Authors:  Peter Vaupel
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

7.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

8.  The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.

Authors:  Gabriel Leprivier; Marc Remke; Barak Rotblat; Adrian Dubuc; Abigail-Rachele F Mateo; Marcel Kool; Sameer Agnihotri; Amal El-Naggar; Bin Yu; Syam Prakash Somasekharan; Brandon Faubert; Gaëlle Bridon; Cristina E Tognon; Joan Mathers; Ryan Thomas; Amy Li; Adi Barokas; Brian Kwok; Mary Bowden; Stephanie Smith; Xiaochong Wu; Andrey Korshunov; Thomas Hielscher; Paul A Northcott; Jason D Galpin; Christopher A Ahern; Ye Wang; Martin G McCabe; V Peter Collins; Russell G Jones; Michael Pollak; Olivier Delattre; Martin E Gleave; Eric Jan; Stefan M Pfister; Christopher G Proud; W Brent Derry; Michael D Taylor; Poul H Sorensen
Journal:  Cell       Date:  2013-05-23       Impact factor: 41.582

Review 9.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

10.  Tumor suppressor protein Pdcd4 interacts with Daxx and modulates the stability of Daxx and the Hipk2-dependent phosphorylation of p53 at serine 46.

Authors:  N Kumar; N Wethkamp; L C Waters; M D Carr; K-H Klempnauer
Journal:  Oncogenesis       Date:  2013-01-14       Impact factor: 7.485

View more
  10 in total

Review 1.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 2.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

3.  Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1).

Authors:  Callie P Wigington; Jeenah Jung; Emily A Rye; Sara L Belauret; Akahne M Philpot; Yue Feng; Philip J Santangelo; Anita H Corbett
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

4.  WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.

Authors:  Mahmood Anber Altayyar; Xiumei Sheng; Zhengxin Wang
Journal:  Mol Cell Biol       Date:  2020-11-20       Impact factor: 4.272

5.  The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.

Authors:  S S Tarighat; R Santhanam; D Frankhouser; H S Radomska; H Lai; M Anghelina; H Wang; X Huang; L Alinari; A Walker; M A Caligiuri; C M Croce; L Li; R Garzon; C Li; R A Baiocchi; G Marcucci
Journal:  Leukemia       Date:  2015-11-05       Impact factor: 11.528

Review 6.  Protein arginine methyltransferases: promising targets for cancer therapy.

Authors:  Jee Won Hwang; Yena Cho; Gyu-Un Bae; Su-Nam Kim; Yong Kee Kim
Journal:  Exp Mol Med       Date:  2021-05-18       Impact factor: 8.718

7.  Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.

Authors:  Antja-Voy Hartley; Benlian Wang; Guanglong Jiang; Han Wei; Mengyao Sun; Lakshmi Prabhu; Matthew Martin; Ahmad Safa; Steven Sun; Yunlong Liu; Tao Lu
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 8.  Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions.

Authors:  Sachiko Matsuhashi; M Manirujjaman; Hiroshi Hamajima; Iwata Ozaki
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

9.  Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis.

Authors:  Zhenzhen Liang; Lianchang Liu; Chaowei Wen; Heya Jiang; Tianxia Ye; Shumei Ma; Xiaodong Liu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 10.  PRMT5 function and targeting in cancer.

Authors:  Hyungsoo Kim; Ze'ev A Ronai
Journal:  Cell Stress       Date:  2020-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.